Evidence map›Paper›PMID 36037263›Full record

ArticleStem cells (Dayton, Ohio)2022

Isolation of an "Early" Transit Amplifying Keratinocyte Population in Human Epidermis: A Role for the Low Affinity Neurotrophin Receptor CD271.

Roberta Lotti, Elisabetta Palazzo, Marika Quadri, Marc Dumas, Sylvianne Schnebert, Diego Biondini, Maria Anastasia Bianchini, Carine Nizard, Carlo Pincelli, Alessandra Marconi

Open access · hybridAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Cell proliferation and differentiation during epidermis renewal.Journal of Zhejiang University. Science. B · 2026
    Review
  2. International journal of molecular sciences · 2026
    Article
  3. Article
  4. Cells · 2025
    Article
  5. Article
  6. Article
  7. The Role of the Neurotrophin Network in Skin Squamous Cell Cancer and the Novel Use of the Zebrafish System.JID innovations : skin science from molecules to population health · 2024
    Review
  8. Article
  9. Article
  10. Transit Amplifying Cells (TACs): a still not fully understood cell population.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Roberta LottiDermoLab, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0003-2126-4147
Elisabetta PalazzoDermoLab, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0002-0812-5524
Marika QuadriDermoLab, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0001-7619-660X
Marc DumasLVMH Recherche, Life Sciences Department, Saint Jean de Braye, France.
Sylvianne SchnebertLVMH Recherche, Life Sciences Department, Saint Jean de Braye, France.
Diego BiondiniPediatric Surgery Unit, Department of Pediatric Surgery, University of Modena and Reggio Emilia, Modena, Italy.
Maria Anastasia BianchiniPediatric Surgery Unit, Department of Pediatric Surgery, University of Modena and Reggio Emilia, Modena, Italy.
Carine NizardLVMH Recherche, Life Sciences Department, Saint Jean de Braye, France.ORCID 0000-0002-6569-8820
Carlo PincelliDermoLab, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0003-4416-2637
Alessandra MarconiDermoLab, Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0002-5667-5766
University of Modena and Reggio Emilia · ITLVMH (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the interfollicular epidermis (IFE), stem cells (KSC) generate transit amplifying (TA) cells that, after symmetric divisions, produce differentiating daughters. Here, we isolated and characterized the highly proliferative interfollicular epidermal basal cell population "early" TA (ETA) cells, based on their capacity to adhere to type IV collagen. Proliferation and colony-forming efficiency in ETA cells are lower than in KSC but higher than in "late" TA (LTA). Stemness, proliferation, and differentiation markers confirmed that ETA cells display a unique phenotype. Skin reconstructs derived from ETA cells present different features (epidermal thickness, Ki67, and Survivin expression), as compared to skin equivalents generated from either KSC or LTA cells. The low-affinity neurotrophin receptor CD271, which regulates the KSC to TA cell transition in the human epidermis through an on/off switch control mechanism, is predominantly expressed in ETA cells. Skin equivalents generated from siRNA CD271 ETA cells display a more proliferative and less differentiated phenotype, as compared to mock-derived reconstructs. Consistently, CD271 overexpression in LTA cells generates a more proliferative skin equivalent than mock LTA cells. Finally, the CD271 level declines with cellular senescence, while it induces a delay in p16INK4 expression. We conclude that ETA cells represent the first KSC progenitor with exclusive features. CD271 identifies and modulates ETA cells, thus participating in the early differentiation and regenerative capacity of the human epidermis.

Indexed as

Epidermal CellsKeratinocytesCell DifferentiationCell ProliferationEpidermisHumansNerve Tissue ProteinsReceptors, Nerve Growth FactorSkinNerve Tissue ProteinsNGFR protein, humanReceptors, Nerve Growth FactorCD271early TA cellsepidermal differentiationepidermal regenerationepidermal stem cellssenescenceskin

Identifiers

PMID36037263
PMCPMC9806768
OpenAlexW4293469912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.